Harman v. Lyphomed, Inc.

734 F. Supp. 294, 1990 U.S. Dist. LEXIS 3824, 1990 WL 42574
CourtDistrict Court, N.D. Illinois
DecidedApril 4, 1990
Docket88 C 0476
StatusPublished
Cited by3 cases

This text of 734 F. Supp. 294 (Harman v. Lyphomed, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Harman v. Lyphomed, Inc., 734 F. Supp. 294, 1990 U.S. Dist. LEXIS 3824, 1990 WL 42574 (N.D. Ill. 1990).

Opinion

MEMORANDUM OPINION AND ORDER

HART, District Judge.

The court has previously approved the settlement of this class action. Still pending is the petition for attorney’s fees, which are to be paid out of the settlement fund. The class received a base settlement amount of $9,900,000. As of January 31, 1990, the settlement fund also included an additional $600,000 1 of interest. The fund has not yet been distributed to the class, apparently pending resolution of the attorney’s fees issue. One member of the class appeared at the settlement hearing and raised objections to the fee petition. Regardless of how many class members object to the fee petition, this court has a duty to determine if the fees are reasonable. Purdy v. Security Savings & Loan Association, 727 F.Supp. 1266, 1269 (E.D.Wis.1989).

Counsel for plaintiffs request a percentage of the base settlement amount. They request an award of 30% of the base settlement amount, which is $2,997,000. Alternatively, counsel request a lodestar amount of $1,376,423 times a 2.177 multiplier for a total of $2,996,473. 2 Counsel also request $131,900 for expenses.

This case began as a number of separate cases brought by various plaintiffs. Subsequently, the individual cases were either dismissed or consolidated and one class action was brought with most of the plaintiffs in the separate cases being named plaintiffs in the one remaining case. A shareholders’ derivative action was also consolidated with the class action. The lawsuit sought damages for alleged securities fraud and also sought to reform manufacturing practices of the corporation. The fraud and other misconduct centered around violations of the United States Food and Drug Act and regulations thereunder. Prior to these suits, Lyphomed had been the subject of investigations by the FDA and some of the alleged fraud related to public statements regarding these investigations. Prior to the settlement of this suit, the FDA had already ordered, and Lyphomed had consented to, certain reforms. Although, class counsel represents certain reforms at Lyphomed as a success of this suit, the settlement provides for, at most, modest reforms in addition to what the FDA had already obtained. The suit was successful in obtaining about $10,000,-000 for the class and the court found this to be a fair settlement. Class counsel state that this is probably about half' of what actual damages to the class were. While the settlement is fair, it is not an “extraordinary damage recovery” as counsel claims. Also, when originally proposed, the settlement was arranged in a manner that may have required members of the class who still owned Lyphomed stock to pay a portion of the settlement in that Lyphomed itself, which they owned a portion of, would pay the settlement. Thus, the settlement would have been worth less than the $9,900,000. Counsel for plaintiffs failed to point out this significant factor when presenting the proposed settlement to the court. The issue, however, later became moot because all the stock of Lyphomed was bought by another corpora *296 tion, so that, at the time the settlement was approved, no class member still owned any Lyphomed stock. It should also be noted that this case did not involve protracted litigation. The case was filed in January 1988. Substantial settlement negotiations began in November 1988. A memorandum of understanding was reached in April 1989 and a stipulation of settlement was entered into in June 1989. The court does recognize, however, that, prior to settlement, defendants were not cooperative in providing discovery.

When the various suits were initially consolidated into one class action, this court warned counsel that fees would not be awarded for duplicative work resulting from the large number of attorneys involved in the case. Nevertheless, a fee petition has been presented which contains attorney’s fees of $1,432,115 based on 6,678 hours of work by 61 different attorneys at 10 firms in Chicago, New York City, and Philadelphia. 3 Work was done by 31 partners, 28 associates, 4 and 2 student associates. 5 Counsel argue that not as many attorneys worked on the case as it may appear, since a number of the attorneys billed an insignificant amount of time. Eighteen attorneys billed less than 10 hours, 19 billed 10 to 49 hours, 9 billed 50 to 99 hours, and 15 billed 100 hours or more. This is still a large number of attorneys billing a substantial amount of time and it appears that such circumstances resulted in otherwise unnecessary duplication of effort. Cf. Procter & Gamble Co. v. Weyerhaeuser Co., 711 F.Supp. 904, 905 (N.D.Ill.1989). This is borne out by the specific billings discussed below.

The rates billed are excessive. In the 4 Chicago firms, partners billed an hourly rate of $195 to $300, associates $105 to $175, and paralegals $60 to $65. In the 4 New York firms, partners billed an hourly rate of $275 to $375, associates $120 6 to $240, and paralegals $70 to $100. In the 2 Philadelphia firms, partners billed an hourly rate of $260 to $325, associates $130 to $285, and paralegals $60 to $70.

Considering that a bulk of the work claimed by the attorneys consisted of discovery (primarily of documents), the bulk of the work should have been performed by those charging lower rates, i.e., the associates and paralegals. Nevertheless, 3 more partners than associates participated in this case. More to the point, partners billed 3076 hours, whereas associates only billed about 13% more (3472 hours 7 ), and paralegals only billed for 808 hours. Partners billed $760,954 for an average hourly rate of $247. Associates billed $658,536 for an average hourly rate of $190. Categorized by rate, 31% of the hours were billed at $120 to $175, 34% at $180 to $225, 10% at $230 to $270, 17% at $275 to $320, and 8% at $325 to $375.

Counsel’s initial fee petition generally did not specify time devoted to specific activities. The only summaries were summaries of the time and lodestar for each attorney and law firm. This petition did not provide a sufficient basis for analyzing the request. See FMC Corp. v. Varonos, 892 F.2d 1308, 1316-17 (7th Cir.1990). The court ordered counsel to provide a breakdown of charges for the class certification motion, fairness hearing brief, and court appearances. Counsel submitted these items, but provided a separate submission from each law firm and some of the law firms divided it up by attorney. Nowhere were the amounts totalled. Nowhere is there one chronological submission so that it can be readily determined which activities were being performed at the same time by dif *297 ferent attorneys. Not even the charges for appearances are organized by appearance date. No subtotals are provided as to certain types of activity, e.g., time spent on discovery related to the class certification motion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Harman v. Lyphomed, Inc.
787 F. Supp. 772 (N.D. Illinois, 1992)
Harman v. Lyphomed, Incorporated
945 F.2d 969 (Seventh Circuit, 1991)
Harman v. Lyphomed, Inc.
945 F.2d 969 (Seventh Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
734 F. Supp. 294, 1990 U.S. Dist. LEXIS 3824, 1990 WL 42574, Counsel Stack Legal Research, https://law.counselstack.com/opinion/harman-v-lyphomed-inc-ilnd-1990.